Isorhamnetin Downregulates MMP2 and MMP9 to Inhibit Development of Rheumatoid Arthritis through SRC/ERK/CREB Pathway | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Isorhamnetin Downregulates MMP2 and MMP9 to Inhibit Development of Rheumatoid Arthritis through SRC/ERK/CREB Pathway

Authors:: Xiao-rong Liu; Shuo-fu Li; Wen-ya Mei; Xiang-dan Liu; Ri-bao Zhou

Reference:: Chinese Journal of Integrative Medicine; 2024; 30; 299–310

DOI:: 10.1007/s11655-023-3753-6

See Abstract

Key Words:: Rheumatoid arthritis; fibroblast‑like synoviocytes; isorhamnetin; MMP-2; MMP-9; SRC/ERK/CREB; rats; animal experiments

Back to index